Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Buspirone in the treatment of posttraumatic stress disorder.

Wells BG, Chu CC, Johnson R, Nasdahl C, Ayubi MA, Sewell E, Statham P.

Pharmacotherapy. 1991;11(4):340-3.

PMID:
1923917
2.

Sleep Dynamic Therapy for Cerro Grande Fire evacuees with posttraumatic stress symptoms: a preliminary report.

Krakow BJ, Melendrez DC, Johnston LG, Clark JO, Santana EM, Warner TD, Hollifield MA, Schrader R, Sisley BN, Lee SA.

J Clin Psychiatry. 2002 Aug;63(8):673-84.

PMID:
12197447
3.

Nightmares, insomnia, and sleep-disordered breathing in fire evacuees seeking treatment for posttraumatic sleep disturbance.

Krakow B, Haynes PL, Warner TD, Santana E, Melendrez D, Johnston L, Hollifield M, Sisley BN, Koss M, Shafer L.

J Trauma Stress. 2004 Jun;17(3):257-68.

PMID:
15253098
4.

Fluvoxamine and sleep disturbances in posttraumatic stress disorder.

Neylan TC, Metzler TJ, Schoenfeld FB, Weiss DS, Lenoci M, Best SR, Lipsey TL, Marmar CR.

J Trauma Stress. 2001 Jul;14(3):461-7.

PMID:
11534878
5.

Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone.

Petracca A, Nisita C, McNair D, Melis G, Guerani G, Cassano GB.

J Clin Psychiatry. 1990 Sep;51 Suppl:31-9. Review.

PMID:
2211564
6.

Pharmacotherapeutic treatment of nightmares and insomnia in posttraumatic stress disorder: an overview of the literature.

van Liempt S, Vermetten E, Geuze E, Westenberg H.

Ann N Y Acad Sci. 2006 Jul;1071:502-7. Review.

PMID:
16891608
7.

Clinical effects of the 5-HT1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression.

Robinson DS, Rickels K, Feighner J, Fabre LF Jr, Gammans RE, Shrotriya RC, Alms DR, Andary JJ, Messina ME.

J Clin Psychopharmacol. 1990 Jun;10(3 Suppl):67S-76S.

PMID:
2198303
8.

Post-traumatic stress disorder: symptom profiles in men and women.

Green B.

Curr Med Res Opin. 2003;19(3):200-4.

PMID:
12803734
9.

Buspirone in the treatment of posttraumatic stress disorder.

LaPorta LD, Ware MR.

J Clin Psychopharmacol. 1992 Apr;12(2):133-4. No abstract available.

PMID:
1573035
10.

Remission rates in patients with anxiety disorders treated with paroxetine.

Ballenger JC.

J Clin Psychiatry. 2004 Dec;65(12):1696-707.

PMID:
15641876
11.

Buspirone in the long-term treatment of generalized anxiety disorder.

Feighner JP.

J Clin Psychiatry. 1987 Dec;48 Suppl:3-6. Review.

PMID:
3320034
12.

Buspirone in the management of major depression: a placebo-controlled comparison.

Fabre LF.

J Clin Psychiatry. 1990 Sep;51 Suppl:55-61.

PMID:
2211570
13.

Posttraumatic stress disorder in Israeli combat veterans. Effect of phenelzine treatment.

Lerer B, Bleich A, Kotler M, Garb R, Hertzberg M, Levin B.

Arch Gen Psychiatry. 1987 Nov;44(11):976-81.

PMID:
3314769
14.
15.

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.

Davidson JR, DuPont RL, Hedges D, Haskins JT.

J Clin Psychiatry. 1999 Aug;60(8):528-35.

PMID:
10485635
16.

Efficacy of buspirone in the treatment of posttraumatic stress disorder: an open trial.

Duffy JD, Malloy PF.

Ann Clin Psychiatry. 1994 Mar;6(1):33-7.

PMID:
7951643
17.

Azaspirodecanediones in generalized anxiety disorder: buspirone.

Ortiz A, Pohl R, Gershon S.

J Affect Disord. 1987 Sep-Oct;13(2):131-43. Review.

PMID:
2960708
18.

Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.

Brady KT, Clary CM.

Compr Psychiatry. 2003 Sep-Oct;44(5):360-9.

PMID:
14505296
19.

Buspirone in social phobia.

Schneier FR, Saoud JB, Campeas R, Fallon BA, Hollander E, Coplan J, Liebowitz MR.

J Clin Psychopharmacol. 1993 Aug;13(4):251-6.

PMID:
8376612
20.

Supplemental Content

Support Center